Stevanato Group S.p.A. Ordinary Shares (STVN)

FairStock Score: 38/100 — MIXED

Key Financials

Strengths

• Strong Piotroski F-Score of 8/9 indicating robust financial health across profitability, leverage, and efficiency metrics
• Conservative balance sheet with debt-to-equity of just 0.32, providing financial flexibility

Concerns

• Trades significantly above Graham Number ($9) with negative 90% margin of safety—limited downside protection
• No meaningful dividend despite modest growth—total return depends entirely on multiple expansion

AI Analysis

Stevanato Group S.p.A. Ordinary Shares is a small-cap healthcare company valued at $4.4 billion. The business generates $1.2 billion in annual revenue with a 4.0% net margin. From a quality standpoint, Stevanato shows near-perfect Piotroski F-Score of 8/9 indicating exceptional financial health and healthy Altman Z-Score of 3.5. On valuation, the stock is trading at a premium 27.1x earnings, with trades above its Graham Number with a negative 90% margin. Growth dynamics show revenue growing at 4.8% and profit growth of -1.7%. Our composite FairStock Score of 38/100 reflects below-average fundamentals overall. Investors should weigh the business quality against the current price and their own margin of safety requirements.

Bull Case

Improving fundamentals and sector tailwinds could drive meaningful earnings growth, compressing the effective multiple for patient investors. Operational leverage in the business model means incremental revenue growth could disproportionately boost bottom-line profitability.

Bear Case

Macro headwinds or sector-specific disruption could pressure margins, particularly if competitive intensity increases in the healthcare space. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer